127 related articles for article (PubMed ID: 33558702)
1. Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-κB pathway in mice.
Wang S; Kou B; Chai M; Gao Y; Lin X; Yin L; Chen D; Liu X
Cancer Gene Ther; 2022 Feb; 29(2):202-214. PubMed ID: 33558702
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
Zhang N; Chu ES; Zhang J; Li X; Liang Q; Chen J; Chen M; Teoh N; Farrell G; Sung JJ; Yu J
Oncotarget; 2014 Sep; 5(18):8330-40. PubMed ID: 25327562
[TBL] [Abstract][Full Text] [Related]
3. [Construction of apoptosis-stimulating of p53 protein 2 gene knockout mice and its effect on diethylnitrosamine-induced liver cancer].
Liu XN; Kou BX; Chai MY; Chen DX
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):784-789. PubMed ID: 33053979
[No Abstract] [Full Text] [Related]
4. Phosphorylation of NF-κBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target.
Xu X; Lei Y; Chen L; Zhou H; Liu H; Jiang J; Yang Y; Wu B
J Exp Clin Cancer Res; 2021 Aug; 40(1):253. PubMed ID: 34380537
[TBL] [Abstract][Full Text] [Related]
5. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
6. Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.
Meng Z; Wang X; Gan Y; Zhang Y; Zhou H; Ness CV; Wu J; Lou G; Yu H; He C; Xu R; Huang W
J Hepatol; 2012 Nov; 57(5):1004-12. PubMed ID: 22728874
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
8. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
[No Abstract] [Full Text] [Related]
9. Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.
Zhou Y; Hu L; Tang W; Li D; Ma L; Liu H; Zhang S; Zhang X; Dong L; Shen X; Chen S; Xue R; Zhang S
J Hematol Oncol; 2021 Jan; 14(1):9. PubMed ID: 33413510
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma.
Zhao J; Wu G; Bu F; Lu B; Liang A; Cao L; Tong X; Lu X; Wu M; Guo Y
Hepatology; 2010 Jan; 51(1):142-53. PubMed ID: 20034025
[TBL] [Abstract][Full Text] [Related]
11. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
12. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
Liu X; Xu J; Wang S; Yu X; Kou B; Chai M; Zang Y; Chen D
Int J Oncol; 2017 Oct; 51(4):1291-1299. PubMed ID: 28902369
[TBL] [Abstract][Full Text] [Related]
14. Genetic deletion of AEG-1 prevents hepatocarcinogenesis.
Robertson CL; Srivastava J; Siddiq A; Gredler R; Emdad L; Rajasekaran D; Akiel M; Shen XN; Guo C; Giashuddin S; Wang XY; Ghosh S; Subler MA; Windle JJ; Fisher PB; Sarkar D
Cancer Res; 2014 Nov; 74(21):6184-93. PubMed ID: 25193383
[TBL] [Abstract][Full Text] [Related]
15. SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
Wen LZ; Ding K; Wang ZR; Ding CH; Lei SJ; Liu JP; Yin C; Hu PF; Ding J; Chen WS; Zhang X; Xie WF
Cancer Res; 2018 Aug; 78(16):4680-4691. PubMed ID: 29776962
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
[TBL] [Abstract][Full Text] [Related]
17. ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.
Yang T; Gao Y; Liu D; Wang Y; Wu J; Liu X; Shi Y; Chen D
Biochem Biophys Res Commun; 2019 Jan; 508(3):769-774. PubMed ID: 30528232
[TBL] [Abstract][Full Text] [Related]
18. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway.
Tey SK; Tse EYT; Mao X; Ko FCF; Wong AST; Lo RC; Ng IO; Yam JWP
Cancer Lett; 2017 Dec; 411():150-161. PubMed ID: 28989054
[TBL] [Abstract][Full Text] [Related]
20. The oncogenic role of NS5A of hepatitis C virus is mediated by up-regulation of survivin gene expression in the hepatocellular cell through p53 and NF-κB pathways.
Jiang YF; He B; Li NP; Ma J; Gong GZ; Zhang M
Cell Biol Int; 2011 Dec; 35(12):1225-32. PubMed ID: 21612579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]